Skip to content
★ Sign in to follow
BG

Bruce Gerhardt

Biocept Inc
Total declarations
6
Company
1
▲ Purchases (4 ops.)
€94k
▼ Sales (0 ops.)
—

Latest filing published 06 Jun 2018 for BIOCEPT INC.

Insider track record

Disclosed buys
4
Disclosed sells
0
Signal history

Closed purchases

Market purchases
4

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Bruce Gerhardt: trading record in brief

Bruce Gerhardt appears in our data through filings on Biocept Inc shares, published by SEC (Form 4). The record holds 6 filings, for trades running from 10 February 2014 to 30 January 2018.

The open-market record is one-sided, with 4 purchases worth €94k and not one sale. The totals do not cover 1 filing with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 option exercise. Since January 2018: 1 purchase and no sales on the market.

The median purchase comes to €22k.

The newest entry dates from 6 June 2018: an open-market purchase, in Biocept Inc. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Bruce Gerhardt

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations6 total
  • ▲
    DirectorExecutivesBiocept Inc
    0SEC
    25,000 sharesCommon StockSEC:0001209191-18-036065:0
    Canonical exit: 30 Apr 2018 (T+90)
  • ▲
    DirectorExecutivesBiocept Inc
    55,000 USD38SEC
    50,000 shares@ US$1.1069.7% of flowCommon StockSEC:0001209191-16-146637:0
    Canonical exit: 17 Jan 2017 (T+90)
  • ▲
    DirectorExecutivesBiocept Inc
    25,000 USD32SEC
    25,000 shares@ US$1.0030.3% of flowCommon StockSEC:0001209191-16-117955:0
    Canonical exit: 2 Aug 2016 (T+90)
  • ◇
    DirectorExecutivesBiocept Inc
    0SEC
    8,735 sharesCommon StockSEC:0001209191-15-060070:0
  • ▲
    DirectorExecutivesBiocept Inc
    25,000 USD0SEC
    20,000 shares@ US$1.25Common StockSEC:0001209191-15-015139:0
    Canonical exit: 14 May 2015 (T+90)
  • ●
    DirectorExecutivesBiocept Inc
    10,550 USD0SEC
    1,055 shares@ US$10.00Common StockSEC:0001209191-14-009971:0

6 of 6 declarations